- Filed
- Feb 17, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Feb 17, 2026 | 61.14M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 61.14M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 38.67M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 7.06M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 2.53M sh |
| Capex | Q3 2025 · Sep 30, 2025 | $57.7K |
| Capex | Q3 2025 · Sep 30, 2024 | $695.7K |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | −$9.69M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | −$20.72M |
| Short Term Investments | Q3 2025 · Sep 30, 2025 | $19.18K |
| Short Term Investments | Q3 2025 · Dec 31, 2024 | $135.14K |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $581.61K |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $1.03M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | −$1.33M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $6.3M |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $22.2M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $24.29M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $27.75M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $37.5M |
| Current Assets | Q3 2025 · Sep 30, 2025 | $2.12M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $3.26M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $20.77M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $39.18M |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$0.02 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$0.41 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | −$1.43 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | −$9.27 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$0.02 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$0.41 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −$1.43 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −$9.27 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $2.35M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $9.35M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $5.63M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $15.65M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $2.47M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $8.42M |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $4.3M |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $11.79M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$984.43K |
| Net Income | Q3 2025 · Sep 30, 2025 | −$15.78M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$10.11M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$23.41M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$4.73M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$24.29M |
| Operating Income | Q3 2025 · Sep 30, 2024 | −$9.66M |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | −$24.25M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $145.37K |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $735.19K |
| Cost Of Revenue | Q3 2025 · Sep 30, 2024 | $852.02K |
| Cost Of Revenue | Q3 2025 · Sep 30, 2024 | $2.63M |